Skip to main content Start main content

Drug Discovery and Cancer (D&C)

Patent Name

Author

Patent Number

Original language

一種用於癌症、肥胖、代謝失調、及相關併發症與合併症之精胺酸消耗劑的組成物及用途

Yun Chung Leung, Alisa Sau-wun SHUM

I804691

Chinese (Traditional)

用于促进内体及溶酶体生物降解的碳氢订书肽

Yanxiang Zhao, Shuai Wu, Wenchao YANG, Yunjiao He, Xiaohua Li, Xianxiu Qiu

ZL201710519312.7

Chinese (Simplified)

治疗鼻咽癌的药物组合物

Sibao Chen, Chi Shing Tai, Kam Wah Mok, Chi On Chan

ZL201811049043.3

Chinese (Simplified)

Ctcf转录因子抑制剂及其应用

Chi Bun Ko, Cong Ma, Yajing Zhang, Wing Cheung Chan, Yuk Kam Cheung

ZL201910562893.1

Chinese (Simplified)

Peptides for Specific Inhibition of Jag 1-Notch 1 Pathway

Xuezhen Zhu, Yu Wai Chen, William Tak Hang Chan, Ming Cheung Chow

US11,117,932

English

Hydrocarbon-stapled Polypeptides for Enhancement of Endosome-lysosomal Degradation

Yanxiang Zhao, Shuai Wu, Wenchao Yang, Yunjiao He, Xiaohua Li, Xianxiu Qiu

US10,618,939

English

含炔烃的类黄酮、含叠氮化物的类黄酮和含三唑的类黄酮作为调节剂用于癌症的多药耐药

Ming Cheung Chow, William Tak Hang Chan, Kin Fai Chan, Iris Lai King Wong, Man Chun Law

ZL201380012019.1

Chinese (Simplified)

胞外多糖及其制备方法和应用

Jianyong Wu, Wing Tak Wong, Longqing Li, Angxin Song

ZL202010185241.3

Chinese (Traditional)

Project Title

Project Coordinator

Year

Funding Scheme

Fund Approved

Sponsor / Supporting Parties

IND-enabling Preclinical Studies of Mitochondria-targeting Peptide Mimetics as Novel Anti-cancer Therapeutics

Prof. Zhao Yanxiang

2022

Innovation and Technology Fund - Midstream Research Programme for Universities (ITF-MRP)

HK$ 2,497,800

N/A

Pre-clinical Evaluation of the Pharmacokinetics, Bioavailability, and Toxicity of the Natural IBD-therapeutic Entity, AT

Dr Tai Chi-shing, William

2021

Innovation and Technology Fund - Partnership Research Programme (ITF-PRP)

HK$ 540,000

BP Apollo Limited

Reversal of Drug Resistance in Breast Cancer Stem Cell by Targeting Integrin A2 (ITGA2)

Prof. Chow Ming-cheung, Larry

2020

Innovation and Technology Fund - Innovation and Technology Support Programme (ITF-ITSP)

HK$ 1,199,998

N/A

Humanized ARB-101 Monoclonal Antibody Targeted Therapy Against Malignant Gastrointestinal Cancers: Proof of Concept Study

Dr Wong Sze-chuen, Cesar

2018

Innovation and Technology Fund - University-Industry Collaboration Programme - Matching Grant for Joint Research (ITF-UICP-MGJR)

HK$ 1,150,000

Arbele Limited

Development of ZK002 as a Novel Anti-inflammatory Drug for Diabetic Retinopathy

Dr Tai Chi-shing, William

2017

Innovation and Technology Fund - University-Industry Collaboration Programme - Matching Grant for Joint Research (ITF-UICP-MGJR)

HK$ 1,597,350

Lee's Pharmaceutical (Hong Kong) Limited

Optimizing Orally Delivered Combination Chemotherapy as a Novel Approach to Treating Cancer

Prof. Chow Ming-cheung, Larry

2015

Innovation and Technology Fund - University-Industry Collaboration Programme - Matching Grant for Joint Research (ITF-UICP-MGJR)

HK$ 3,989,637

Athenex HK Innovative Limited

Development of Novel Long-acting Recombinant Human Follicle Stimulating Hormone for Therapeutic Use

Prof. Zhao Yanxiang

2015

Innovation and Technology Fund - Innovation and Technology Support Programme - Tier 3 (ITF-ITSP-Tier 3)

HK$ 1,380,000

Guangzhou UnicoMed Pharma Co. Ltd.

 

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here